Pyxis Oncology, Inc. (PYXS) stock
PYXSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.44+0.03 (+2.13%)
Close on Nov 17, 2026Market cap $120.11MP/E –Yield –
Pyxis Oncology price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Pyxis Oncology's price to sales ratio was 7.7× on Apr 30, 2026.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 7.7× | +3.6 |
| 2025 | Apr 30, 2025 | 4.1× | – |
See a number that looks wrong?